PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Quetiapine - Parkinson's Disease (psychosis)
PAD Profile : Quetiapine - Parkinson's Disease (psychosis)
Keywords :
psychotic symptoms, PD, hallucinations, delusions
Brand Names Include :
Seroquel, Zaluron XL, Ebesque XL, Biquelle XL, Sondate, Tenprolide XL, Mintreleq XL, Atrolak XL
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Quetiapine can be used to treat hallucinations and delusions in Parkinson's Disease (unlicensed use) in patients with no cognitive impairment.
Quetiapine for this condition should only be initiated on request from a Parkinson's specialist. Note added January 2025 - this drug should be prescribed on initiated by a specialist.
Advice must be sought from a specialist in Parkinson's Disease before modifying therapy.
Associated BNF Codes
04. Central Nervous System
04.02.01. Antipsychotic drugs